[1] Speck U, Stolzenburg N, Peters D, et al. How does a drug-coated balloon work? Overview about coating technologies and their impact[J]. J Cardiovasc Surg(Torino), 2015, 57(1):3-11.
[2] Schulz A, Hauschild T, Kleber FX. Treatment of coronary de novo bifurcation lesions with DCB only strategy[J]. Clin Res Cardiol, 2014, 103(6):451-456.
[3] Arslan U, Kocaogˇlu I, Balci MM, et al. Monocyte heterogeneity in myocardial infarction with and without ST elevation and its association with angiographic findings[J]. Coron Artery Dis, 2013, 24(5):404-411.
[4] Scheller B, Clever YP, Kelsch B, et al. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter[J]. JACC Cardiovasc Interv, 2012, 5(3):323-330.
[5] Vos NS, van der Schaaf RJ, Amoroso G, et al. Revascularization with paclitaxel-coated balloon angioplasty versus drug-eluting stenting in acute myocardial infarction—a randomized controlled trial: rationale and design of the revelation trial[J]. Catheter Cardiovasc Interv, 2016, 87(7):1213-1221.
[6] 巫天明. 不同途径经皮冠状动脉介入诊治非心脏并发症的分析[J]. 临床荟萃, 2013, 28(1):61-62.
[7] 李辉, 孙福成, 张慧平, 等. 经皮冠状动脉介入术后脑出血并发症分析[J]. 中国神经免疫学和神经病学杂志, 2013, 20(4):250-252.
[8] Sciahbasi A, Mancone M, Cortese B, et al. Transradial percutaneous coronary interventions using sheathless guiding catheters: a multicenter registry[J]. J Interv Cardiol, 2011, 24(5):407-412.
[9] Unverdorben M, Vallbracht C, Cremers B, et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD Ⅱ ISR study[J]. EuroIntervention, 2015, 11(8):926-934.
[10] Siontis GC, Stefanini GG, Mavridis D, et al. Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis[J]. Lancet, 2015, 386(9994):655-664.
[11] Xu B, Gao R, Wang J, et al. A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial[J]. JACC Cardiovasc Interv, 2014, 7(2):204-211.
[12] Kleber FX, Rittger H, Bonaventura K, et al. Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group[J]. Clin Res Cardiol, 2013, 102(11):785-797.
[13] Brancati MF, Burzotta F, Coluccia V, et al. The occurrence of radial artery occlusion following catheterization[J]. Expert Rev Cardiovasc Ther, 2012, 10(10):1287-1295.
[14] López Mínguez JR, Nogales Asensio JM, Doncel Vecino LJ, et al. A prospective randomised study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions(BABILON trial): 24-month clinical and angiographic results[J]. EuroIntervention, 2014, 10(1):50-57.
[15] Li J, Li X, Wang Q, et al. ST-segment elevation myocardial infarction in China from 2001 to 2011(the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data[J]. Lancet, 2015, 385(9966):441-451.